全文获取类型
收费全文 | 112460篇 |
免费 | 8487篇 |
国内免费 | 5761篇 |
专业分类
耳鼻咽喉 | 331篇 |
儿科学 | 1628篇 |
妇产科学 | 559篇 |
基础医学 | 7515篇 |
口腔科学 | 662篇 |
临床医学 | 15920篇 |
内科学 | 19964篇 |
皮肤病学 | 313篇 |
神经病学 | 11164篇 |
特种医学 | 6641篇 |
外国民族医学 | 2篇 |
外科学 | 16551篇 |
综合类 | 22615篇 |
现状与发展 | 5篇 |
一般理论 | 1篇 |
预防医学 | 4519篇 |
眼科学 | 1096篇 |
药学 | 10579篇 |
63篇 | |
中国医学 | 5905篇 |
肿瘤学 | 675篇 |
出版年
2024年 | 120篇 |
2023年 | 1531篇 |
2022年 | 2349篇 |
2021年 | 4083篇 |
2020年 | 4022篇 |
2019年 | 3266篇 |
2018年 | 3332篇 |
2017年 | 3590篇 |
2016年 | 3843篇 |
2015年 | 3775篇 |
2014年 | 7047篇 |
2013年 | 8163篇 |
2012年 | 6588篇 |
2011年 | 7380篇 |
2010年 | 6267篇 |
2009年 | 5968篇 |
2008年 | 6161篇 |
2007年 | 6277篇 |
2006年 | 5921篇 |
2005年 | 5194篇 |
2004年 | 4316篇 |
2003年 | 3901篇 |
2002年 | 3327篇 |
2001年 | 3086篇 |
2000年 | 2575篇 |
1999年 | 2130篇 |
1998年 | 1784篇 |
1997年 | 1627篇 |
1996年 | 1244篇 |
1995年 | 1171篇 |
1994年 | 999篇 |
1993年 | 800篇 |
1992年 | 692篇 |
1991年 | 602篇 |
1990年 | 508篇 |
1989年 | 403篇 |
1988年 | 381篇 |
1987年 | 334篇 |
1986年 | 286篇 |
1985年 | 365篇 |
1984年 | 285篇 |
1983年 | 168篇 |
1982年 | 185篇 |
1981年 | 178篇 |
1980年 | 136篇 |
1979年 | 93篇 |
1978年 | 68篇 |
1977年 | 69篇 |
1976年 | 43篇 |
1975年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 156 毫秒
11.
《Digestive and liver disease》2022,54(11):1486-1493
BackgroundCold snare polypectomy (CSP) is a promising technique for the removal of sessile serrated polyps (SSPs) ≥ 10 mm. However, the efficacy and safety of this technique remain undetermined.AimsWe aimed to comprehensively evaluate the efficacy and safety of CSP for SSPs ≥ 10 mm.MethodsPubMed, EMBASE, Web of Science and Cochrane Library were searched up to January 2021.ResultsA total of 10 studies consisting of 1727 SSPs (range, 10–40 mm) from 1021 patients were included. The overall rates of technical success, adverse events (AEs) and residual SSPs were 100%, 0.7% and 2.9%, respectively. Subgroup analysis showed that the rates of technical success and AEs were comparable between CSP and cold endoscopic mucosal resection (EMR) (99.9% vs. 100% and 1.3% vs. 0.5%, respectively), between the proximal and distal colon (100% vs. 99.9% and 0.3% vs. 0, respectively), and between polyps of 10–19 mm and ≥20 mm (99.8% vs. 100% and 0.9% vs. 0, respectively). However, subgroup analysis showed that the rate of residual SSPs was slightly lower in CSP compared with cold EMR (1.3% vs. 3.9%), as well as in polyps of 10–19 mm compared with those ≥20 mm (3.1% vs. 4.7%).ConclusionCSP was an effective and safe technique for removing SSPs ≥ 10 mm. 相似文献
12.
《Clinical microbiology and infection》2022,28(8):1152.e1-1152.e6
ObjectivesDespite the possibility of concurrent infection with COVID-19 and malaria, little is known about the clinical course of coinfected patients. We analysed the clinical outcomes of patients with concurrent COVID-19 and malaria infection.MethodsWe conducted a retrospective cohort study that assessed prospectively collected data of all patients who were admitted between May and December 2020 to the Universal COVID-19 treatment center (UCTC), Khartoum, Sudan. UCTC compiled demographic, clinical, laboratory (including testing for malaria), and outcome data in all patients with confirmed COVID-19 hospitalized at that clinic. The primary outcome was all-cause mortality during the hospital stay. We built proportional hazard Cox models with malaria status as the main exposure and stepwise adjustment for age, sex, cardiovascular comorbidities, diabetes, and hypertension.ResultsWe included 591 patients with confirmed COVID-19 diagnosis who were also tested for malaria. Mean (SD) age was 58 (16.2) years, 446/591 (75.5%) were males. Malaria was diagnosed in 270/591 (45.7%) patients. Most malaria patients were infected by Plasmodium falciparum (140/270; 51.9%), while 121/270 (44.8%) were coinfected with Plasmodium falciparum and Plasmodium vivax. Median follow-up was 29 days. Crude mortality rates were 10.71 and 5.87 per 1000 person-days for patients with and without concurrent malaria, respectively. In the fully adjusted Cox model, patients with concurrent malaria and COVID-19 had a greater mortality risk (hazard ratio 1.43, 95% confidence interval 1.21-1.69).DiscussionCoinfection with COVID-19 and malaria is associated with increased all-cause in-hospital mortality compared to monoinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 相似文献
13.
14.
目的 基于网络药理学探讨并分析筒鞘蛇菰(Balanophora involucrata Hook. f.,BIH)治疗肝损伤的作用及分子机制,并通过大鼠体内实验验证相关预测靶点及筒鞘蛇菰提取物-蛇菰多糖(Polysaccharides of Balanophora involucrata Hook. f.,BPS)对实验性肝损伤的保护作用。方法 化学专业数据库、TCMID和TCMSP平台检索筒鞘蛇菰组成的化合物及可能靶点,以肝损伤为关键词检索GeneCards和网站,获得相关靶点,绘制Venn图,选交集靶点,将“化合物-靶点和疾病-靶点”关系导入Cytoscape V3.7.2软件,获得化合物-靶点-疾病的三重网络,对化合物及相关靶点蛋白行分子对接,并用交集靶点绘制蛋白互作网络图及进行GO生物功能和KEGG信号途径富集分析。结果 筒鞘蛇菰主要成分有11个化合物,其中与肝损伤有37个交集靶点,高度关联靶点包括NOS3、ESR1、TNF、MAOA、PTGS2、IL10等,GO和KEGG富集分析发现筒鞘蛇菰治疗肝损伤的分子机制,可能与调节肾上腺素能信号通路、cGMP-PKG信号及神经活性配体-受体交互通路等有关,而且ADRA1B、ADRA2A、ADRA2C、ADRB1/2等基因高度富集于这些通路中。动物体内实验发现BPS灌胃处理可减轻肝组织损伤、调控血清炎症因子肿瘤坏死因子α(Tumor necrosis factor, TNF-α)和白细胞介素10(IL-10)水平、提高抗氧化酶超氧化物歧化酶(superoxide dismutase,SOD)活性,并增强肝组织内氧化应激相关蛋白核因子E2相关因子2(NF-E2-related factor 2,NRF2)和醌NADH脱氢酶1(NQO1)的表达,从而抑制大鼠体内氧化应激损伤、减轻炎症反应和细胞凋亡,达到保护实验性肝损伤的作用。结论 本研究初步确定筒鞘蛇菰治疗肝损伤的有效成分、“化合物-蛋白-靶点”关联网络及发挥作用的分子机制,并通过动物体内实验证实蛇菰多糖保护肝损伤的机制与上调NRF2/NQO1通路来减轻氧化应激反应性损伤、减轻肝细胞凋亡有关。 相似文献
15.
Oxidative stress and inflammation are two possible mechanisms related to nephrotoxicity caused by environmental pollutants. Ellagic acid, a powerful antioxidant phytochemical, may have great relevance in mitigating pollutant-induced nephrotoxicity and preventing the progression of kidney disease. This review discusses the latest findings on the protective effects of ellagic acid, its metabolic derivatives, the urolithins, against kidney toxicity caused by heavy metals, pesticides, mycotoxins, and organic air pollutants. We describe the chelating, antioxidant, anti-inflammatory, antifibrotic, antiautophagic, and antiapoptotic properties of ellagic acid to attenuate nephrotoxicity. Furthermore, we present the molecular targets and signaling pathways that are regulated by these antioxidants, and suggest some others that should be explored. Nevertheless, the number of reports is still limited to establish the efficacy of ellagic acid against kidney damage induced by environmental pollutants. Therefore, additional preclinical studies on this topic are required, as well as the development of well-designed clinical trials. 相似文献
16.
17.
ObjectiveTo cross-culturally adapt and evaluate the psychometric properties of the University of Wisconsin Running Injury and Recovery Index questionnaire in Spanish (UWRI-S) in Chilean runners with a running-related injury.DesignCross-cultural adaptation and validation study, following the Consensus-based Standards for selecting health Measurement Instruments (COSMIN) recommendations.SettingOutpatient sports medicine clinic and running clubs.ParticipantsUWRI was forward and backward translated, and culturally adapted. Thirty-one runners participated in the content validity of the UWRI-S; and fifty-seven in the assessment of psychometric properties.Main outcome measuresRunners seeking care from a physiotherapist completed the UWRI-S (baseline and after 48–72 h for reliability), Lower Extremity Functional Scale (LEFS), Patient Specific Functional Scale (PSFS), Global Rating of Change scale (GROC), and Numeric Pain Rating Scale (NPRS).ResultsSuggestions about accuracy of wording and understanding of items were incorporated. UWRI-S showed a positive moderate correlation with LEFS (r = 0.6; p < 0.05), positive fair with GROC (r = 0.5, p < 0.05), negative fair with NPRS (r = −0.4; p < 0.05) and no correlation with PSFS (r = 0.3; p = 0.1). UWRI-S demonstrated acceptable internal consistency (α = 0.87) and test-retest reliability (ICC = 0.87).ConclusionUWRI-S is a valid and reliable measure to evaluate running ability of Chilean runners during recovery from a running-related injury. 相似文献
18.
19.
20.
目的了解何首乌致药物性肝损伤(Polygonum multiflorum-associated drug induce liver injury,PM-DILI)的临床病理学特点。方法收集2019年3月1日至2021年3月1日深圳市第三人民医院收治的8例PM-DILI患者临床资料。肝穿组织进行苏木素-伊红染色、网状纤维染色、Masson三色染色、铁、铜特殊染色和免疫组织化学染色,显微镜下观察分析。结果8例PM-DILI患者男女比为1∶1,平均年龄43岁,其中6例为急性PM-DILI,2例慢性为PM-DILI。入院血清学检查异常主要包括转氨酶升高和淤胆均为7例。主要组织病理学改变为点灶状坏死8例、界面炎5例、融合坏死4例,融合坏死以肝腺泡3带为主,不伴或伴少数炎细胞浸润;胆汁淤积5例,为肝腺泡3带的肝细胞、毛细胆管内淤胆,不伴或伴少数炎细胞浸润;中央静脉炎3例;病程长者可发生肝纤维化,甚至肝硬化2例。结论肝腺泡3带为主的急性淤胆和肝细胞坏死是PM-DILI主要组织学表现,严重者可发生静脉炎等血管损伤。 相似文献